Cargando...
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
Besides treating acute flares, the management of SLE should aim at preventing organ damage accrual and drug-associated harms, improving health-related quality of life and prolonging survival. At present, therapy is based on combinations of antimalarials (mainly HCQ), considered the backbone of SLE t...
Guardado en:
| Publicado en: | Rheumatology (Oxford) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7719039/ https://ncbi.nlm.nih.gov/pubmed/33280011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa403 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|